Health Condition 1: - Health Condition 2: J00-J99- Diseases of the respiratory system
Conditions
Interventions
Intervention1: Fluticasone nasal spray: Single dose daily in allergic rhinitis for 12 weeks
Control Intervention1: Fluticasone Nasal spray: Single dose in alternative day in allergic rhinitis for 12
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of both genders belonging to age group 6-60 years having clinical diagnosis on the basis of history and examination of allergic rhinitis symptoms. 2. Both seasonal and perennial allergic rhinitis .
Exclusion criteria
Exclusion criteria: 1. Patients who have undergone nasal surgery and immunotherapy for the purpose of treating AR. 2. Patients with nasal diseases, like nasal polyp, ear deviated nasal septum, infectious diseases like acute rhinitis, chronic rhinitis, congestive sinusitis, atrophic rhinitis, chronic rhinosinusitis flu associated rhinitis, membrane perforations. 3.Patients with diabetes mellitus, asthma, hypertension and women who wanted to become pregnant or pregnant women or breast feeding women. 4. Patients with psychaitric illness. 5. Patients aged below the 6 years. 6. Patients aged above the 60 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison between daily and alternate day regimen of fluticasone intranasal spray for allergic rhinitis.Timepoint: Daily and alternate day regimen of fluticasone intranasal spray for allergic rhinitis in baseline 8 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of symptom relief in both therapy regimens.Timepoint: Daily & alternate day symptom relief in both therapy regimens in baseline 8 weeks 12 weeks | — |
Countries
India
Contacts
Public ContactDr Nikhat Anjum
Adichunchanagiri Institute of Medical Sciences
Outcome results
None listed